Inhibrx Biosciences Inc (INBX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Inhibrx Biosciences Inc (INBX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Inhibrx Biosciences Inc

· INBX

Dashboard

Financials

Ratios

Valuation

Statistics

1.543 B

-4.53%

General

Market Cap: $1.54B
Enterprise Value: $1.34B
Shares Outstanding: 14,670,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -89.60%
ROE: 1893.60%
ROIC: -99.35%
Current Ratio: 5.07
Debt-to-Equity: -0.10
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -11.13

Growth

Rev 1Y: 550.00%
Rev 1Y Fwd Est: 230.77%
Rev 3Y (CAGR): -15.98%
Rev 5Y (CAGR): -36.72%
Rev 10Y (CAGR): —
EPS 1Y: -107.75%
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $126.13M
Operating Income: -$127.81M
Net Profit: -$138.18M

Balance Sheet

Cash and Equivalents: $133.34M
Working Capital: $114.15M
Total Assets: $154.22M
Net Debt: -$128M
Total Liabilities: $207.2M
Total Equity: -$52.98M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$131.89M
Cash Flow from Investing: $20K
Cash Flow from Financing: $78.67M
Free Cash Flow: -$131.87M
Capital Expenditures: -$17K